Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-14-002157
Filing Date
2014-07-16
Accepted
2014-07-16 17:59:47
Documents
2
Period of Report
2014-07-15

Document Format Files

Seq Description Document Type Size
1 form3-07162014_020739.html 3  
1 form3-07162014_020739.xml 3 1665
2 ex24-07162014_020739.htm EX-24 3180
  Complete submission text file 0001415889-14-002157.txt   6216
Mailing Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SUITE 100 SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 14978864